SEC Form 4 · accession 0001209191-16-136788
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Zaccardelli
Director
Period of report
Aug 10, 2016
Accepted (ET)
Aug 12, 2016 · 4:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $22.77 | Aug 10, 2016 | A | 25,000 | A | — | Aug 10, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The option vests on the following schedule: 1/12th of the shares vest monthly at the end of each month over 12 months, beginning after 08/10/2016.